نتایج جستجو برای: enoxaparin

تعداد نتایج: 1833  

Journal: :European review for medical and pharmacological sciences 2013
A Demirtas I Azboy M Bulut B Y Ucar U Alabalik N S Necmioglu

BACKGROUND Today, there is a small number of studies on the effects of Enoxaparin and Fondaparinux used commonly in the prevention of venous thromboembolism on healing of fracture cases. AIM The aim of this study was to investigate clinically, radiologically and histopathologically, the effects of Enoxaparin, Fondaparinux and Rivaroxaban used in thromboembolism prophylaxis on fracture healing...

Journal: :Orthopedics 2013
Kunihiro Hosaka Shu Saito Takao Ishii Takanobu Sumino Keinosuke Ryu Gen Suzuki Takashi Suzuki Yasuaki Tokuhashi

Fondaparinux and enoxaparin are useful for preventing venous thromboembolism after total knee arthroplasty (TKA), but both drugs have associated complications. The purpose of this study was to clarify the risks associated with use of these drugs in Japanese patients who underwent TKA.A total of 575 patients (935 knees) underwent TKA and were retrospectively reviewed; 277 patients (454 knees) we...

Journal: :Vascular Health and Risk Management 2007
Caroline Schmidt-Lucke Heinz-Peter Schultheiss

Non-ST elevation acute coronary syndrome (NSTE-ACS) refers to a cardiovascular disorder characterized by intracoronary thrombus formation on a disrupted atherosclerotic plaque with partial or transient occlusion. Generation of thrombin resulting from exposure of collagen leads to activation of platelets and conversion offibrinogen to fibrin, thus forming a platelet-rich thrombus. The main thera...

Journal: :The journal of extra-corporeal technology 2001
R J Kohtz C M Petterson N J Mills S A Kmiecik J L Liu J D Nichols T S Vaadia A H Stammers

The use of low molecular weight heparins (LMWH) as an anticoagulant in the heparin-resistant patient poses challenges during cardiopulmonary bypass (CPB). The ultrafiltrability of LMWH has not been previously examined. The purpose of this study was to determine the effects of continuous ultrafiltration on the concentraton of a LMWH, enoxaparin. An in vitro analysis was performed using fresh who...

Journal: :South African General Practitioner 2021

Journal: :Acta biochimica Polonica 2011
Natalia Krześniak Agnieszka Paziewska Tymon Rubel Magdalena Skrzypczak Michał Mikula Artur Dzwonek Krzysztof Goryca Lucjan S Wyrwicz Dorota Jarosz Daniel Laubitz Marek Woszczyński Krzysztof Bielecki Jerzy Ostrowski

Colon anastomosis is therapeutically challenging because multiple, usually undetectable factors influence a spectrum of repair mechanisms. We hypothesized that low molecular weight heparins, routinely administered perioperatively, may differentially affect gene expression related to colon healing. Twenty pairs of untreated and enoxaparin-treated rats underwent left-side hemicolectomy with a pri...

2011
Nady Braidy Khai Bui Beata Bajorek

UNLABELLED The short-comings of current anticoagulants have led to the development of newer, albeit more expensive, oral alternatives. OBJECTIVE To explore the potential impact the new anticoagulants dabigatran and rivaroxaban in the local hospital setting, in terms of utilisation and subsequent costing. METHOD A preliminary costing analysis was performed based on a prospective 2-week clini...

Journal: :Circulation 1994
D P Faxon T E Spiro S Minor G Coté J Douglas R Gottlieb R Califf K Dorosti E Topol J B Gordon

BACKGROUND Heparin, an anticoagulant, possesses antiproliferative effects and has been shown to reduce neointimal proliferation and restenosis following vascular injury in experimental studies. METHODS AND RESULTS The primary aim of this double-blind multicenter study was to determine if 40 mg Enoxaparin, a low molecular weight heparin, administered subcutaneously once daily for 1 month after...

Journal: :Blood 2004
Jean-Christophe Gris Eric Mercier Isabelle Quéré Géraldine Lavigne-Lissalde Eva Cochery-Nouvellon Médéric Hoffet Sylvie Ripart-Neveu Marie-Laure Tailland Michel Dauzat Pierre Marès

The prospective evaluation of the effect of thromboprophylaxis in women with one unexplained pregnancy loss from the 10th week of amenorrhea was performed. A total of 160 patients with heterozygous factor V Leiden mutation, prothrombin G20210A mutation, or protein S deficiency were given 5 mg folic acid daily before conception, to be continued during pregnancy, and low-dose aspirin 100 mg daily...

Journal: :American journal of obstetrics and gynecology 1999
H L Casele S A Laifer D A Woelkers R Venkataramanan

OBJECTIVE We sought to evaluate the pharmacokinetics of subcutaneously administered enoxaparin sodium during and after pregnancy. STUDY DESIGN Daily subcutaneous injections of enoxaparin sodium (40 mg) were administered to 13 pregnant women. On 3 separate occasions, once early in pregnancy (12-15 weeks), once late in pregnancy (30-33 weeks), and once in the nonpregnant state (6-8 weeks post p...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید